
Qinghai Jinrui Mineral Development Co., Ltd specializes in the manufacturing and distribution of a comprehensive range of strontium-based chemicals. Their extensive product portfolio includes various strontium salts, such as both industrial and electronic grades of strontium carbonate, along with metal strontium, aluminum-strontium alloys, strontium nitrate, strontium hydroxide, and strontium sulfate. The company also supplies by-products like sulfur, sodium sulfite, and sodium sulfate, as well as other related compounds. These materials find widespread utility across numerous industrial applications, including electronics, metallurgy, the chemical sector, aviation, automotive manufacturing, and emerging new energy technologies. Established in 1996 and headquartered in Xining, China, the company originally operated as Mountains in Qinghai Ferroalloy Co., Ltd before adopting its current name.
Qinghai Jinrui Mineral Development Co., Ltd trades as 600714.SS on SHH. The company is classified in Basic Materials / Industrial Materials and reports in CNY.
The current profile places the business in Industrial Materials. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.
Detailed operating-segment data is not available for this symbol yet.
Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.
The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.
Qinghai Jinrui Mineral Development Co., Ltd can be compared against peers such as Lets Holdings Group Co., Ltd., Shandong Polymer Biochemicals Co., Ltd., Guangdong Xianglu Tungsten Co., Ltd., Hangzhou Yitong New Material Co., Ltd., Ningbo Color Master Batch Co., Ltd., Sichuan Golden Summit (group) Joint-Stock Co., Ltd..
A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.
Current signals to investigate include market capitalization of $8.31B, beta of 0.97, and return on equity of N/A.
This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.
Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.
600714.SS currently shows total debt of N/A and beta of 0.97. Missing data should be treated as a research gap, not as low risk.
Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.
No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.
Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.
No recent SEC-style filings are available for this symbol yet.
Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.
Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.
Company website: http://www.china-shanchuan.com
For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.